Skip to main content
Log in

Lymphangiome: Der aktuelle Stellenwert der Therapie mit OK-432

  • Originalarbeit
  • Published:
Pädiatrie & Pädologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ogita S, Tsuto T and Tokiwa K et al (1987). Intracystic injection of OK-432: A new sclerosing therapy for cystic hygroma in children. Br J of Surg 74: 690–691

    Article  CAS  Google Scholar 

  2. Ishida N, Hoshino T. A streptococcal preparation as a potent biological response modifier OK-432. Excerpta Medica, 1985, 2nd ed, Amsterdam

  3. Schmidt B, Schimpl G and Höllwarth M (1996). OK-432 therapy of lymphangiomas in children. Eur J Pediatr 155: 649–652

    Article  PubMed  CAS  Google Scholar 

  4. Sichel JY, Udassin R and Gozal D et al (2004). OK-432 therapy for cervical lymphangioma. Laryngoscope 114: 1805–1809

    Article  PubMed  CAS  Google Scholar 

  5. Hall N, Ade-Ajayi N and Brewis C et al (2003). Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children. Surgery 133: 238–242

    Article  PubMed  Google Scholar 

  6. Okazaki T, Iwatani S and Yanai T et al (2007). Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 42: 386–389

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mircia-Aurel Ardelean.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ardelean, MA., Bauer, J., Schulz, U. et al. Lymphangiome: Der aktuelle Stellenwert der Therapie mit OK-432. Paediatr. Paedolog. Austria 43, 32–35 (2008). https://doi.org/10.1007/s00608-008-0093-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00608-008-0093-x

Navigation